{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:02:07Z","timestamp":1787212927581,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["S\/06\/23"],"award-info":[{"award-number":["S\/06\/23"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cjca.2025.02.035","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T16:15:30Z","timestamp":1741450530000},"page":"1241-1250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"41","author":[{"given":"Mauro","family":"Gitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Pasquale","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Gilhooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Di Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuram Melarcode","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.02.035_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005375","article-title":"Mortality from ischemic heart disease","volume":"12","author":"Nowbar","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ehjqcco\/qcac045","article-title":"Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017","volume":"8","author":"Kobo","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ehjqcco\/qcac016","article-title":"Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019","volume":"9","author":"Raisi-Estabragh","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ehf2.12551","article-title":"Recent advances in cardio-oncology: a report from the \u201cHeart Failure Association 2019 and World Congress on Acute Heart Failure 2019.\u201d","volume":"6","author":"Anker","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2025.02.035_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/ejhf.1539","article-title":"Cancer and heart disease: associations and relations","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2025.02.035_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.02.035_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2025.02.035_bib8","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0049-3848(14)50009-6","article-title":"Bleeding complications during anticoagulant treatment in patients with cancer","volume":"133","author":"Kamphuisen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2025.02.035_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaccao.2019.11.001","article-title":"Ischemia and bleeding in cancer patients undergoing percutaneous coronary intervention","volume":"1","author":"Ueki","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cjca.2025.02.035_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/ehjqcco\/qcx047","article-title":"Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study","volume":"4","author":"Tabata","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib11","first-page":"200","article-title":"Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study---Kyoto Registry Cohort-2)","volume":"4","author":"Nakatsuma","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib12","first-page":"631","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjca.2025.02.035_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014383","article-title":"Temporal trends in the prevalence of cancer and its impact on outcome in patients with first myocardial infarction: a nationwide study","volume":"9","author":"Velders","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.02.035_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001779","article-title":"Relationship between cancer and cardiovascular outcomes following percutaneous coronary intervention","volume":"4","author":"Hess","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.02.035_bib15","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","article-title":"Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States","volume":"40","author":"Potts","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.02.035_bib16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehaa1032","article-title":"Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA","volume":"42","author":"Kwok","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.02.035_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jcin.2021.03.049","article-title":"Cancer patients have a higher risk of thrombotic and ischemic events after percutaneous coronary intervention","volume":"14","author":"Guo","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.02.035_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.amjcard.2021.08.021","article-title":"Impact of active and historical cancer on short- and long-term outcomes in patients with acute myocardial infarction","volume":"159","author":"Matsumoto","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib19","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.02.035_bib20","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.amjcard.2013.08.019","article-title":"Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention","volume":"112","author":"Velders","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/jcdd10040135","article-title":"Dual antiplatelet therapy and cancer; balancing between ischemic and bleeding risk: a narrative review","volume":"10","author":"Tsigkas","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.cjca.2025.02.035_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2023.100607","article-title":"Antiplatelet strategies following PCI: a review of trials informing current and future therapies","volume":"2","author":"Thomas","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interventions"},{"key":"10.1016\/j.cjca.2025.02.035_bib23","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","article-title":"Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level","volume":"65","author":"Barac","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2025.02.035_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.02.035_bib26","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib27","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.02.035_bib28","article-title":"Validation of a high bleeding risk definition in cancer patients undergoing percutaneous coronary intervention","author":"Gitto","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcin.2013.04.016","article-title":"An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry","volume":"6","author":"Rao","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.02.035_bib30","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib31","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.02.035_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.02.035_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.cjca.2025.02.035_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.013000","article-title":"Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials","volume":"17","author":"Campos","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.02.035_bib35","first-page":"E202","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.02.035_bib36","first-page":"1244","article-title":"Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes","volume":"18","author":"Koshy","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjca.2025.02.035_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007434","article-title":"Use of prasugrel and ticagrelor in stable ischemic heart disease after percutaneous coronary intervention, 2009-2016","volume":"12","author":"Dayoub","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2025.02.035_bib38","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/eurheartj\/ehae463","article-title":"Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score","volume":"45","author":"Dafaalla","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.02.035_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008359","article-title":"Trends in arterial access site selection and bleeding outcomes following coronary procedures, 2011-2018","volume":"15","author":"Doll","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2025.02.035_bib40","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.02.035_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaccao.2022.01.102","article-title":"Does cardiovascular mortality overtake cancer mortality during cancer survivorship?: An English retrospective cohort study","volume":"4","author":"Strongman","year":"2022","journal-title":"JACC CardioOncol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:13:19Z","timestamp":1787170399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0828282X25001795"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.02.035","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}